Rilpivirine Hydrochloride
Who holds supplier records for Rilpivirine Hydrochloride? 9 organisations hold a current record for Rilpivirine Hydrochloride: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (5), Belgium (1), United States (1) and China (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Rilpivirine Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/rilpivirine-hydrochloride
Reading the evidence
- 9 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
5 of the 8 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (9)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Rilpivirine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Cipla LimitedIndia Company GMP cert on recordActive DMF 30773 · latest filing Jan 2017
- Hetero Drugs LimitedIndia Company GMP cert on recordActive DMF 29301 · latest filing Apr 2015
- Janssen Pharmaceutica NVBelgium Company GMP cert on recordActive DMF 23824 · latest filing Jul 2010
- Laurus Labs LimitedIndia Company GMP cert on recordActive DMF 29841 · latest filing Dec 2015
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 27253 · latest filing Jul 2013
- MSN PHARMACHEM PRIVATE LTDIndiaActive DMF 30423 · latest filing Mar 2016
- NAVINTA LLCUnited StatesActive DMF 39324 · latest filing Apr 2026
- REYOUNG CORPORATIONActive DMF 37479 · latest filing Sept 2022
- Shanghai Desano Chemical Pharmaceutical Co., LtdChinaActive DMF 26305, 39552 · latest filing Feb 2024
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Rilpivirine Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1628504).
Chemical identity
- IUPAC name
- 4-[[4-[4-[(E)-2-cyanoethenyl]-2,6-dimethylanilino]pyrimidin-2-yl]amino]benzonitrile;hydrochloride
- Canonical SMILES
- CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)/C=C/C#N.Cl
- InChIKey
- KZVVGZKAVZUACK-BJILWQEISA-N
- Synonyms
- Edurant, Edurant ped, Rilpivirine (as hydrochloride), Rilpivirine hcl, Rilpivirine hydrochloride, Rilpivirine hydrochloride component of complera, Rilpivirine hydrochloride component of eviplera, Rilpivirine hydrochloride component of juluca, Rilpivirine hydrochloride component of odefsey, TMC-278 HYDROCHLORIDE, TMC278 HYDROCHLORIDE, CHEBI:68602
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
- Mechanism of action
- Non-Nucleoside Reverse Transcriptase Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Rilpivirine Hydrochloride?
9 organisations hold an active US FDA Type II Drug Master File or a CEP for Rilpivirine Hydrochloride: Cipla Limited (India), Hetero Drugs Limited (India), Janssen Pharmaceutica NV (Belgium), Laurus Labs Limited (India), MATRIX PHARMACORP PRIVATE LTD (India), MSN PHARMACHEM PRIVATE LTD (India), NAVINTA LLC (United States) and REYOUNG CORPORATION, and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Rilpivirine Hydrochloride Drug Master Files are active?
Cipla Limited (DMF 30773), Hetero Drugs Limited (DMF 29301), Janssen Pharmaceutica NV (DMF 23824), Laurus Labs Limited (DMF 29841), MATRIX PHARMACORP PRIVATE LTD (DMF 27253), MSN PHARMACHEM PRIVATE LTD (DMF 30423), NAVINTA LLC (DMF 39324) and REYOUNG CORPORATION (DMF 37479) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
How do I qualify a Rilpivirine Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Rilpivirine Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.